In Vitro Methods for Estimating Unbound Drug Concentrations in the Brain Interstitial and Intracellular Fluids
- 25 June 2007
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 35 (9), 1711-1719
- https://doi.org/10.1124/dmd.107.015222
Abstract
Concentrations of unbound drug in the interstitial fluid of the brain are not rapidly measured in vivo. Therefore, measurement of total drug levels, i.e., the amount of drug per gram of brain, has been a common but unheplful practice in drug discovery programs relating to central drug effects. This study was designed to evaluate in vitro techniques for faster estimation of unbound drug concentrations. The parameter that relates the total drug level and the unbound interstitial fluid concentration is the unbound volume of distribution in the brain (Vu,brain). It was measured in vitro for 15 drugs using brain slice uptake and brain homogenate binding methods. The results were validated in vivo by comparison with Vu,brain microdialysis results. The slice method results were within a 3-fold range of the in vivo results for all but one compound, suggesting that this method could be used in combination with total drug levels to estimate unbound interstitial fluid concentrations within reasonable limits. Although successful in 10 of 15 cases, the brain homogenate binding method failed to estimate the Vu,brain of drugs that reside predominantly in the interstitial space or compounds that are accumulated intracellularly. Use of the simple methods described in this article will 1) allow quantification of active transport at the blood-brain barrier in vivo, 2) facilitate the establishment of a relationship between in vitro potency and in vivo activity for compounds acting on central nervous system targets, and 3) provide information on intracellular concentrations of unbound drug.Keywords
This publication has 37 references indexed in Scilit:
- In Vivo Blood-Brain Barrier Transport of Oxycodone in the Rat: Indications for Active Influx and Implications for Pharmacokinetics/PharmacodynamicsDrug Metabolism and Disposition, 2006
- Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous SystemPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2006
- EVALUATION OF THE UTILITY OF BRAIN SLICE METHODS TO STUDY BRAIN PENETRATIONPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2006
- Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathologyNeurochemistry International, 2004
- Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical SettingClinical Pharmacokinetics, 2002
- Blood‐brain barrier transport and brain distribution of morphine‐6‐glucuronide in relation to the antinociceptive effect in rats – pharmacokinetic/pharmacodynamic modellingBritish Journal of Pharmacology, 2001
- Development of anIn SituMouse Brain Perfusion Model and its Application tomdr1aP-Glycoprotein-Deficient MiceJournal of Cerebral Blood Flow & Metabolism, 2000
- Measuring agreement in method comparison studiesStatistical Methods in Medical Research, 1999
- Octanol−, Chloroform−, and Propylene Glycol Dipelargonat−Water Partitioning of Morphine-6-glucuronide and Other Related OpiatesJournal of Medicinal Chemistry, 1996
- Measurement in Medicine: The Analysis of Method Comparison StudiesJournal of the Royal Statistical Society: Series D (The Statistician), 1983